Sep 2026· Food Science and Human Wellness· 0 citations
TL;DR
This paper systematically reviews the research mechanisms, different research models, and the development of novel delivery systems of proanthocyanidins in cancer prevention and treatment, providing theoretical basis for promoting the translation of proanthocyanidins from basic research to clinical applications.
Abstract
Cancer is one of the leading causes of death worldwide, and its high incidence and mortality pose a significant threat to public health. Studies show that more than two-thirds of cancer-related deaths could be prevented through changes in lifestyle, especially dietary patterns. Proanthocyanidins, as a class of polyphenolic compounds widely present in the diet, have attracted wide attention due to their high safety and good biological tolerance. Studies have found that proanthocyanidins have shown multifaceted potential in cancer prevention and treatment. Their mechanisms involve inducing cell apoptosis and cell cycle arrest, improving the tumor immune microenvironment, regulating tumor-related signaling pathways, inhibiting angiogenesis, and suppressing invasion and metastasis, etc. This paper systematically reviews the research mechanisms, different research models, and the development of novel delivery systems of proanthocyanidins in cancer prevention and treatment. It also explores the challenges of current research and future translational directions, providing theoretical basis for promoting the translation of proanthocyanidins from basic research to clinical applications.
Despite promising preclinical results across various models, the clinical translation of nobiletin is hindered by poor oral bioavailability, complex extraction, and limited human data, so novel delivery systems offer potential solutions to enhance its bioavailability.
Szymon Sip, Anna Gościniak, Niklas Hoede et al.· Antioxidants· 0 citations
This review aims to examine and discuss current research on the molecular targets and mechanisms of action of whole cherry extracts and their primary flavonols quercetin and kaempferol across various breast cancer subtypes.
Evangelia K. Konstantinou, K. Dimiza, Maria Dimitriou et al.· International Journal of Mol...· 0 citations
It is suggested that phytochemicals act as multi-target compounds rather than single cytotoxic agents with promising potential in combination therapies for colorectal cancer.
Muhammad Adil, G. S. Dawe, V. Subramaniyan· Journal of materials chemist...· 0 citations
This review provides a theoretical basis for Isorhamnetin's anti-tumor mechanism and supports its clinical translational potential as a new strategy for cancer treatment.
Yan-Yu Hua, Xin Shen, Shu-Qi Niu et al.· Anti-Cancer Agents in Medici...· 0 citations
Key Ayurvedic phytochemicals-based nature, such as curcumin, withaferin A, nimbolide, berberine, and eugenol, are examined, detailing their mechanisms in inhibiting cancer, including apoptosis induction, cell cycle arrest, as well as tumor angiogenesis suppression.
Y. Narkhede, N. V. Borse· Genetics and Molecular Resea...· 0 citations
Cancer is a major global health challenge, with p53 mutations occurring in
over 50% of human cancers and contributing to impaired DNA repair and apoptosis. In more recent
work, phytochemicals in herbs such as curcumin, resveratrol, genistein, berberine, and withaferin A
were found to enhance p53 activity or rescue...
Neha Verma, S. Chakraborty, Juhikaben Vaibhavkumar Patel et al.· Current Cancer Therapy Revie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.